ASF1B promotes cervical cancer progression through stabilization of CDK9

Cervical cancer (CC) is one of the most deadly cancers in women, its current treatments still result in poor outcomes and developing the novel targets and therapeutic strategies are urgently needed. Recent studies have shown that anti-silencing function 1B (ASF1B) might be used as a new proliferatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xinjian, Song, Jingwei, Zhang, Yenan, Wang, Huiquan, Sun, Hongzhi, Feng, Xiaomin, Hou, Min, Chen, Guo, Tang, Qi, Ji, Minjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449975/
https://www.ncbi.nlm.nih.gov/pubmed/32848135
http://dx.doi.org/10.1038/s41419-020-02872-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449975/
https://www.ncbi.nlm.nih.gov/pubmed/32848135
http://dx.doi.org/10.1038/s41419-020-02872-5

Ejemplares similares